Search research articles
Contact Us
Filters
Showing results (121-130 of 144) with videos related to
Page
of 15
Sort By:
Virulence
|
May 12, 2026
Clinical and genomic profiling of <i>Klebsiella pneumoniae</i> in liver abscesses
Felix Aurnhammer, Maxim M Baltzer, Jamil Butt, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2013
Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates
Thomas V Magee, Seungil Han, Sandra P McCurdy, et al.
Scientific Reports
|
April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Scientific Reports
|
January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Journal of Geriatric Oncology
|
August 6, 2016
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study
Mary M Huerter, Jane L Meza, M Sitki Copur, et al.
Analytical Biochemistry
|
August 4, 2009
Purification of the large ribosomal subunit via its association with the small subunit
Samuel P Simons, Thomas J McLellan, Paul A Aeed, et al.
Journal of Medicinal Chemistry
|
January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors
Thomas A Chappie, John M Humphrey, Martin P Allen, et al.
Analytical Biochemistry
|
January 27, 1999
Spontaneous alpha-N-6-phosphogluconoylation of a "His tag" in Escherichia coli: the cause of extra mass of 258 or 178 Da in fusion proteins
K F Geoghegan, H B Dixon, P J Rosner, et al.
Cancer Treatment and Research Communications
|
November 2, 2019
A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study
Vinicius Ernani, Rahat Jahan, Lynette M Smith, et al.
Journal of Medicinal Chemistry
|
July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia
Patrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 144) with videos related to
Sort By:
Page
of 15
Virulence
|
May 12, 2026
Clinical and genomic profiling of <i>Klebsiella pneumoniae</i> in liver abscesses
Felix Aurnhammer, Maxim M Baltzer, Jamil Butt, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2013
Novel 3-O-carbamoyl erythromycin A derivatives (carbamolides) with activity against resistant staphylococcal and streptococcal isolates
Thomas V Magee, Seungil Han, Sandra P McCurdy, et al.
Scientific Reports
|
April 11, 2019
Author Correction: Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Scientific Reports
|
January 19, 2018
Dopamine D3 receptor antagonist reveals a cryptic pocket in aminergic GPCRs
Noelia Ferruz, Stefan Doerr, Michelle A Vanase-Frawley, et al.
Journal of Geriatric Oncology
|
August 6, 2016
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study
Mary M Huerter, Jane L Meza, M Sitki Copur, et al.
Analytical Biochemistry
|
August 4, 2009
Purification of the large ribosomal subunit via its association with the small subunit
Samuel P Simons, Thomas J McLellan, Paul A Aeed, et al.
Journal of Medicinal Chemistry
|
January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitors
Thomas A Chappie, John M Humphrey, Martin P Allen, et al.
Analytical Biochemistry
|
January 27, 1999
Spontaneous alpha-N-6-phosphogluconoylation of a "His tag" in Escherichia coli: the cause of extra mass of 258 or 178 Da in fusion proteins
K F Geoghegan, H B Dixon, P J Rosner, et al.
Cancer Treatment and Research Communications
|
November 2, 2019
A phase I study of weekly doxorubicin and oral topotecan for patients with relapsed or refractory small cell lung cancer (SCLC): A Fred and Pamela Buffet Cancer Center Clinical Trials Network study
Vinicius Ernani, Rahat Jahan, Lynette M Smith, et al.
Journal of Medicinal Chemistry
|
July 28, 2009
Discovery of a novel class of phosphodiesterase 10A inhibitors and identification of clinical candidate 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the treatment of schizophrenia
Patrick R Verhoest, Douglas S Chapin, Michael Corman, et al.
Page
of 15